Lechleiter: Rx adherence is part of fix for high care costs

07/22/2013 | Forbes

The value of prescription drugs is illustrated by the way health care costs go up when people don't take their medications, Eli Lilly and Co. CEO and former PhRMA Chairman John Lechleiter writes, The entire health care system, and not just individual patients, would benefit if patients adhered to their prescriptions. The drug industry is committed to seeing that everyone has access to prescription drugs as the health care system looks for ways to help boost adherence, he writes.

View Full Article in:

Forbes